BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu S, Imani S, Deng Y, Pathak JL, Wen Q, Chen Y, Wu J. Targeting IFN/STAT1 Pathway as a Promising Strategy to Overcome Radioresistance. Onco Targets Ther 2020;13:6037-50. [PMID: 32606809 DOI: 10.2147/OTT.S256708] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Li S, Feng J, Weng H, Zhao F, Cui G, Fu W, Lin X, Hu H. Identification of Key Genes and FUNCTIONAL Pathway in Radioresistance of Non-Small Cell Lung Cancer. Cancer Manag Res 2022;14:2871-84. [PMID: 36171861 DOI: 10.2147/CMAR.S382079] [Reference Citation Analysis]
2 Wu L, Wang D, Chen Y, Qian M, Xu X, Zhang T, Bi N, Wang L. Dynamic change of IDO1 activity predicts survival in patients with unresectable stage III NSCLC and chemoradiotherapy. Front Immunol 2022;13:906815. [DOI: 10.3389/fimmu.2022.906815] [Reference Citation Analysis]
3 Wu B, Sodji QH, Oyelere AK. Inflammation, Fibrosis and Cancer: Mechanisms, Therapeutic Options and Challenges. Cancers 2022;14:552. [DOI: 10.3390/cancers14030552] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
4 James NE, Woodman M, Ribeiro JR. Prognostic immunologic signatures in epithelial ovarian cancer. Oncogene 2022. [PMID: 35031772 DOI: 10.1038/s41388-022-02181-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 Reed MR, Lyle AG, De Loose A, Maddukuri L, Learned K, Beale HC, Kephart ET, Cheney A, van den Bout A, Lee MP, Hundley KN, Smith AM, Desrochers TM, Vibat CRT, Gokden M, Salama S, Wardell CP, Eoff RL, Vaske OM, Rodriguez A. A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma. Cells 2021;10:3400. [DOI: 10.3390/cells10123400] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
6 Liao WC, Lin TJ, Liu YC, Wei YS, Chen GY, Feng HP, Chang YF, Chang HT, Wang CL, Chi HC, Wang CI, Lin KH, Ou Yang WT, Yu CJ. Nuclear accumulation of KPNA2 impacts radioresistance through positive regulation of the PLSCR1-STAT1 loop in lung adenocarcinoma. Cancer Sci 2021. [PMID: 34773335 DOI: 10.1111/cas.15197] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Raspaglio G, Buttarelli M, Filippetti F, Battaglia A, Buzzonetti A, Scambia G, Gallo D. Stat1 confers sensitivity to radiation in cervical cancer cells by controlling Parp1 levels: a new perspective for Parp1 inhibition. Cell Death Dis 2021;12:933. [PMID: 34642300 DOI: 10.1038/s41419-021-04229-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Liu W, Miao C, Zhang S, Liu Y, Niu X, Xi Y, Guo W, Chu J, Lin A, Liu H, Yang X, Chen X, Zhong C, Ma Y, Wang Y, Zhu S, Liu S, Tan W, Lin D, Wu C. VAV2 is required for DNA repair and implicated in cancer radiotherapy resistance. Signal Transduct Target Ther 2021;6:322. [PMID: 34462423 DOI: 10.1038/s41392-021-00735-9] [Reference Citation Analysis]
9 Lin S, Shen Z, Yang Y, Qiu Y, Wang Y, Wang X. Expression profiles of radio-resistant genes in colorectal cancer cells. Radiation Medicine and Protection 2021;2:48-54. [DOI: 10.1016/j.radmp.2021.04.006] [Reference Citation Analysis]